97 related articles for article (PubMed ID: 25051113)
1. Specific and efficient gene delivery mediated by an asialofetuin-associated nanosystem.
Farinha D; Pedroso de Lima MC; Faneca H
Int J Pharm; 2014 Oct; 473(1-2):366-74. PubMed ID: 25051113
[TBL] [Abstract][Full Text] [Related]
2. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
3. Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid.
Magalhães M; Farinha D; Pedroso de Lima MC; Faneca H
Int J Nanomedicine; 2014; 9():4979-89. PubMed ID: 25368518
[TBL] [Abstract][Full Text] [Related]
4. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
Sakashita M; Mochizuki S; Sakurai K
Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
[TBL] [Abstract][Full Text] [Related]
6. Folate-associated lipoplexes mediate efficient gene delivery and potent antitumoral activity in vitro and in vivo.
Duarte S; Faneca H; Lima MC
Int J Pharm; 2012 Feb; 423(2):365-77. PubMed ID: 22209825
[TBL] [Abstract][Full Text] [Related]
7. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
[TBL] [Abstract][Full Text] [Related]
8. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
9. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
[TBL] [Abstract][Full Text] [Related]
10. Serum-resistant lipoplexes in the presence of asialofetuin.
Tros de Ilarduya C
Methods Mol Biol; 2010; 605():425-34. PubMed ID: 20072898
[TBL] [Abstract][Full Text] [Related]
11. Targeted liposomes to deliver DNA to cells expressing 5-HT receptors.
Gopal V; Xavier J; Dar GH; Jafurulla M; Chattopadhyay A; Rao NM
Int J Pharm; 2011 Oct; 419(1-2):347-54. PubMed ID: 21855617
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated liposomes with proton sponge capacity: novel hepatocyte- specific gene carriers.
Habib S; Singh M; Ariatti M
Curr Drug Deliv; 2013 Dec; 10(6):685-95. PubMed ID: 23859358
[TBL] [Abstract][Full Text] [Related]
13. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
14. Novel synthetic LPDs consisting of different cholesterol derivatives for gene transfer into hepatocytes.
Lu J; Zhu D; Zhang ZR; Hai L; Wu Y; Sun X
J Drug Target; 2010 Aug; 18(7):520-35. PubMed ID: 20067439
[TBL] [Abstract][Full Text] [Related]
15. Liver targeting liposomes containing beta-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells.
Kawano K; Nakamura K; Hayashi K; Nagai T; Takayama K; Maitani Y
Biol Pharm Bull; 2002 Jun; 25(6):766-70. PubMed ID: 12081144
[TBL] [Abstract][Full Text] [Related]
16. Novel galactosylated polyamine bolaamphiphiles for gene delivery.
Fabio K; Gaucheron J; Di Giorgio C; Vierling P
Bioconjug Chem; 2003; 14(2):358-67. PubMed ID: 12643746
[TBL] [Abstract][Full Text] [Related]
17. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
Díez S; Navarro G; de ILarduya CT
J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
[TBL] [Abstract][Full Text] [Related]
18. Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2.
Narainpersad N; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):206-23. PubMed ID: 22356236
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
[TBL] [Abstract][Full Text] [Related]
20. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
